Thermo Fisher Scientific Inc

More Details of Thermo Fisher Scientific Inc Company

Thermo Fisher Scientific Inc. is engaged in accelerating life sciences research, solving complex analytical challenges, increasing laboratory productivity, and improving patient health through diagnostics and the development and manufacture of life-changing therapies. Through its Life Sciences Solutions segment, the Company provides a portfolio of reagents, instruments and consumables used in biological and medical research, discovery and production of new drugs and vaccines as well as diagnosis of infection and disease. Through its Analytical Instruments segment, the Company provides an offering of instruments and the supporting consumables, software and services that are used for a range of applications. The Company’s Specialty Diagnostics segment offers a range of diagnostic test kits, reagents, culture media, instruments and associated products to serve customers in healthcare, clinical, pharmaceutical, industrial, and food safety laboratories.

Company Info

Company codeTMO

Company nameThermo Fisher Scientific Inc

IPO dateAug 27, 1980

Founded at1960

CEOMr. Marc N. Casper

Number of employees125000

Security typeOrdinary Share

Fiscal year-endAug 27

Address168 Third Avenue

CityWALTHAM

Stock exchangeNYSE Consolidated

CountryUnited States of America

Postal code02451

Phone17816221000

Websitehttps://www.thermofisher.com/

Company codeTMO

IPO dateAug 27, 1980

Founded at1960

Company Executives

Name

Name/Position

Position

Shareholding

Change

Mr. Marc N. Casper

Chairman of the Board, President, Chief Executive Officer

172.49K

--

Mr. Scott M. Sperling

Lead Independent Director

72.41K

+0.47%

Mr. Stephen Williamson

Chief Financial Officer, Senior Vice President

30.37K

+26.31%

Mr. Gianluca Pettiti

Executive Vice President

17.12K

+74.12%

Mr. Michel Lagarde

Chief Operating Officer, Executive Vice President

17.03K

+90.54%

Mr. Nelson J. Chai

Independent Director

13.86K

-0.12%

Ms. Lisa P. Britt

Chief Human Resource Officer, Senior Vice President

13.80K

+28.80%

Mr. Michael A. Boxer

Senior Vice President, General Counsel

8.87K

-29.85%

Dr. Tyler Jacks

Director

8.01K

+4.42%

Ms. Ruby R. Chandy

Independent Director

2.01K

+20.32%

Name

Name/Position

Position

Shareholding

Change

Mr. Marc N. Casper

Chairman of the Board, President, Chief Executive Officer

172.49K

--

Mr. Scott M. Sperling

Lead Independent Director

72.41K

+0.47%

Mr. Stephen Williamson

Chief Financial Officer, Senior Vice President

30.37K

+26.31%

Mr. Gianluca Pettiti

Executive Vice President

17.12K

+74.12%

Mr. Michel Lagarde

Chief Operating Officer, Executive Vice President

17.03K

+90.54%

Mr. Nelson J. Chai

Independent Director

13.86K

-0.12%

Revenue Breakdown

Currency: USDUpdate time: Wed, Apr 2

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2021

FY2020

FY2019

By BusinessUSD

Name

Revenue

Proportion

Service

17.84B

41.62%

Consumables

17.59B

41.02%

Instruments

7.45B

17.37%

By RegionUSD

Name

Revenue

Proportion

United States

21.75B

50.74%

Europe

10.86B

25.32%

Asia Pacific

7.96B

18.55%

Other Regions

1.56B

3.64%

Northern America excluded united states

749.00M

1.75%

By Business

By Region

By BusinessUSD

Name

Revenue

Proportion

Service

17.84B

41.62%

Consumables

17.59B

41.02%

Instruments

7.45B

17.37%

Shareholder

Update time: Fri, Feb 21

Shareholder Statistics

Type

Shareholder Statistics

Shareholder

Proportion

The Vanguard Group, Inc.

8.77%

BlackRock Institutional Trust Company, N.A.

4.56%

State Street Global Advisors (US)

4.36%

T. Rowe Price Associates, Inc.

2.74%

Capital World Investors

2.50%

Other

77.07%

Shareholder Statistics

Shareholder

Proportion

The Vanguard Group, Inc.

8.77%

BlackRock Institutional Trust Company, N.A.

4.56%

State Street Global Advisors (US)

4.36%

T. Rowe Price Associates, Inc.

2.74%

Capital World Investors

2.50%

Other

77.07%

Type

Shareholder

Proportion

Investment Advisor

42.52%

Investment Advisor/Hedge Fund

36.92%

Bank and Trust

2.87%

Research Firm

2.84%

Pension Fund

2.56%

Hedge Fund

2.24%

Sovereign Wealth Fund

1.99%

Foundation

0.28%

Family Office

0.21%

Other

7.58%

Institutional Shareholding

Update time: Thu, Feb 20

Reporting Period

No. of institutions

Shares Held

Proportion

Change

2025Q1

4272

350.09M

92.79%

-3.93M

2024Q4

4330

349.72M

92.67%

-4.90M

2024Q3

4195

348.49M

91.10%

-6.75M

2024Q2

4169

349.06M

91.37%

-3.26M

2024Q1

4150

346.74M

90.80%

-11.10M

2023Q4

4145

353.49M

91.48%

-3.65M

2023Q3

4035

353.30M

91.43%

-5.83M

2023Q2

4030

357.37M

92.63%

+1.15M

2023Q1

3992

353.61M

91.65%

-5.21M

2022Q4

3961

356.99M

91.02%

-2.42M

Shareholder Activity

Name

Shares Held

Proportion

Change

Chg %

Date

The Vanguard Group, Inc.

33.08M

8.77%

+201.59K

+0.61%

Dec 31, 2024

BlackRock Institutional Trust Company, N.A.

17.20M

4.56%

+65.72K

+0.38%

Dec 31, 2024

State Street Global Advisors (US)

16.45M

4.36%

+129.07K

+0.79%

Dec 31, 2024

T. Rowe Price Associates, Inc.

10.33M

2.74%

-64.57K

-0.62%

Dec 31, 2024

Capital World Investors

9.43M

2.5%

+104.34K

+1.12%

Dec 31, 2024

Capital Research Global Investors

7.92M

2.1%

-266.96K

-3.26%

Dec 31, 2024

Geode Capital Management, L.L.C.

7.86M

2.08%

+197.44K

+2.58%

Dec 31, 2024

Norges Bank Investment Management (NBIM)

6.05M

1.6%

+483.36K

+8.68%

Dec 31, 2024

Fidelity Management & Research Company LLC

5.69M

1.51%

-1.59M

-21.86%

Dec 31, 2024

JP Morgan Asset Management

5.66M

1.5%

+1.37M

+31.89%

Dec 31, 2024

Related ETFs

Update time: Wed, Apr 2

Name

Proportion

Amplify Weight Loss Drug & Treatment ETF

5.26%

Monarch Blue Chips Core ETF

4.2%

JPMorgan Healthcare Leaders ETF

3.94%

AdvisorShares Focused Equity ETF

3.85%

Honeytree US Equity ETF

3.83%

Invesco Nasdaq Free Cash Flow Achievers ETF

3.75%

Indexperts Quality Earnings Focused ETF

3.74%

Proshares Ultra Health Care

3.73%

Health Care Select Sector SPDR Fund

3.72%

iShares U.S. Healthcare ETF

3.61%

Amplify Weight Loss Drug & Treatment ETF

Proportion5.26%

Monarch Blue Chips Core ETF

Proportion4.2%

JPMorgan Healthcare Leaders ETF

Proportion3.94%

AdvisorShares Focused Equity ETF

Proportion3.85%

Honeytree US Equity ETF

Proportion3.83%

Invesco Nasdaq Free Cash Flow Achievers ETF

Proportion3.75%

Indexperts Quality Earnings Focused ETF

Proportion3.74%

Proshares Ultra Health Care

Proportion3.73%

Health Care Select Sector SPDR Fund

Proportion3.72%

iShares U.S. Healthcare ETF

Proportion3.61%

Dividend

A total of 2.29B USD has been distributed in dividends over the past 5 years.

Date

Dividend

Record Date

Payment Date

Ex-dividend Date

Feb 19, 2025

TMO.NB Interim Cash Dividend of gross USD 0.43 paid on Apr 15, 2025 going ex on Mar 14, 2025

Mar 14, 2025

Apr 15, 2025

Mar 14, 2025

Nov 07, 2024

TMO.NB Interim Cash Dividend of gross USD 0.39 paid on Jan 15, 2025 going ex on Dec 13, 2024

Dec 13, 2024

Jan 15, 2025

Dec 13, 2024

Jul 11, 2024

TMO.NB Final Cash Dividend of gross USD 0.39 paid on Oct 15, 2024 going ex on Sep 13, 2024

Sep 13, 2024

Oct 15, 2024

Sep 13, 2024

May 22, 2024

TMO.NB Interim Cash Dividend of gross USD 0.39 paid on Jul 15, 2024 going ex on Jun 14, 2024

Jun 14, 2024

Jul 15, 2024

Jun 14, 2024

Feb 21, 2024

TMO.NB Interim Cash Dividend of gross USD 0.39 paid on Apr 15, 2024 going ex on Mar 14, 2024

Mar 15, 2024

Apr 15, 2024

Mar 14, 2024

Nov 09, 2023

TMO.NB Interim Cash Dividend of gross USD 0.35 paid on Jan 16, 2024 going ex on Dec 14, 2023

Dec 15, 2023

Jan 16, 2024

Dec 14, 2023

Jul 13, 2023

TMO.NB Final Cash Dividend of gross USD 0.35 paid on Oct 13, 2023 going ex on Sep 14, 2023

Sep 15, 2023

Oct 13, 2023

Sep 14, 2023

May 24, 2023

TMO.NB Interim Cash Dividend of gross USD 0.35 paid on Jul 14, 2023 going ex on Jun 14, 2023

Jun 15, 2023

Jul 14, 2023

Jun 14, 2023

Feb 22, 2023

TMO.NB Interim Cash Dividend of gross USD 0.35 paid on Apr 14, 2023 going ex on Mar 14, 2023

Mar 15, 2023

Apr 14, 2023

Mar 14, 2023

Nov 10, 2022

TMO.NB Interim Cash Dividend of gross USD 0.3 paid on Jan 16, 2023 going ex on Dec 14, 2022

Dec 15, 2022

Jan 16, 2023

Dec 14, 2022

Stock Split

Date

Type

Ratio

No Data

Date

Type

Ratio

No Data

470.030USD

Thermo Fisher Scientific Inc

470.030

Overview

Company